Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Beghin-Meiji | INDUSTRY |
Digestive symptoms following consumption of low digestibe carbohydrates are generally assessed product by product but several ingredients can be used simultaneously. The study aimed at evaluating to digestive tolerance of maltitol and FOS used in a same food.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| sugary dessert cream | Placebo Comparator |
| |
| maltitol alone | Experimental |
| |
| maltitol 85% / FOS 15% | Experimental |
| |
| maltitol 68% / FOS 32% | Experimental |
| |
| maltitol 50% / FOS 50% | Experimental |
| |
| FOS alone | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| maltitol 85% / FOS15% | Other |
| ||
| maltitol alone |
| Measure | Description | Time Frame |
|---|---|---|
| Composite score of gastrointestinal symptoms in the 24h following the consumption of products | 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Individual scores of gastrointestinal symptoms: bloating, abdominal discomfort, borborygms, flatulences | 24 and 48 hours | |
| Stool frequcency and consistency | 24 & 48 hours | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Gendre, MD | Biofortis SAS | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Biofortis SAS | Saint-Herblain | 44800 | France |
Not provided
| ID | Term |
|---|---|
| C010745 | maltitol |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| maltitol 68% / FOS 32% | Other |
|
| maltitol 50% / FOS 50% | Other |
|
| FOS alone | Other |
|
| Placebo | Other |
|
| Glycaemic response |
| 2 hours |